Tetraphase Pharmaceuticals Announces FDA Acceptance for Filing of its NDA Submission for Eravacycline Pharmaceutical Investing
Actinium Pharmaceuticals Announces Activation of Sixteenth Clinical Trial Site in the Pivotal Phase 3 SIERRA Trial for Iomab-B Pharmaceutical Investing
Amarin Reports Record Fourth Quarter and Full Year 2017 Financial Results and Provides Update on Operations Pharmaceutical Investing
Verona Pharma Reports Operational Update and Financial Results for Full Year Ended December 31, 2017 Pharmaceutical Investing
TESARO Announces Collaboration to Evaluate Combination of ZEJULA® (Niraparib) and Anti-PD-L1 Cancer Immunotherapy Pharmaceutical Investing
EMERGENT BIOSOLUTIONS AND VALNEVA INITIATE PHASE 1 CLINICAL STUDY TO EVALUATE VACCINE CANDIDATE AGAINST ZIKA VIRUS Biotech Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
